High-dose Intravenous Vitamin C (HDIVC) as Adjuvant Therapy in Critical Patients With Positive COVID-19. A Pilot Randomized Controlled Dose-comparison Trial.
Clinical trial NCT05029037 · UNKNOWN
Trial details
- NCT number
- NCT05029037
- Sponsor
- Hugo Galindo
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2022-03-15
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.